Director, Health Care Innovation and Value Initiative, The Brookings Institution
Mark McClellan, M.D., Ph.D., focuses on promoting quality and value in patient-centered health care. A physician and economist by training, Dr. McClellan has a highly distinguished record in public service and in academic research.
He is a former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy, including the Medicare prescription drug benefit, the FDA's Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care.
Dr. McClellan chairs the FDA's Reagan-Udall Foundation, is co-chair of the Quality Alliance Steering Committee, sits on the National Quality Forum's board of directors, is a member of the Institute of Medicine, and is a research associate at the National Bureau of Economic Research.
He previously served as a member of the Council of Economic Advisers and senior director for health care policy at the White House, and he was an associate professor of economics and medicine at Stanford University.
May 27, 2014